Home Health News Liver Disease Drug Pulled From the Market By News Health 3 weeks Ago Share on FacebookShare on Twitter (MedPage Today) — Intercept Pharmaceuticals has pulled obeticholic acid (Ocaliva) from the U.S. market as a treatment for primary biliary cholangitis (PBC) after the FDA requested its removal and placed ongoing trials on clinical hold. The move… Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/117441 Author : Publish date : 2025-09-12 16:37:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say By News Health October 3, 2025 Ahead of Shutdown, Most Americans Said They Wanted ACA Tax Credits Extended By News Health October 3, 2025 Medical Groups Call for Physician Exemptions to Trump's Executive Order By News Health October 3, 2025 Chronic Back Pain in Seniors May Ease With Acupuncture By News Health October 3, 2025 Missed Mammogram Warning; NCI Chief Installed; 'Father of Palliative Care' Dies By News Health October 3, 2025 FDA Approves Maintenance Combo for Small Cell Lung Cancer By News Health October 3, 2025